National Center for Tumor Diseases (NCT) Heidelberg

Heidelberg 69120

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Colorectal Cancer Stage II, Colorectal Cancer Stage III

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer — Running, not enrolling